The full-length NS3 peptide sequence in West Nile and Dengue viruses represents a multifunctional protein. The N-terminal 184 amino acid-long fragment of NS3 represents the NS3 proteinase. The C-terminal portion of the NS3 protein encodes a nucleotide triphosphatase, an RNA triphosphatase and a helicase. The NS3 proteinase is required for the maturation of the virus. The NS3 proteinase is responsible for cleaving the NS2a/NS2b, NS2b/NS3, NS3/NS4a and NS4b/NS5 junction regions. This proteinase is also responsible for the cleavage at the C-terminal region of the C protein. As is the case with a number of flaviviruses, the NS2b protein, that is located in the polypeptide precursor upstream of the NS3 proteinase, functions as a cofactor and promotes the proteolytic activity of the NS3 enzyme. The cofactor activity of the 40 amino acid long central portion of the NS2b is roughly equivalent to that of the entire NS2b sequence. Most importantly, inactivating mutations of the NS3 cleavage sites in the polyprotein precursor abolish virus infectivity. We hypothesize that the processing NS3 proteinase, which is an essential component of the virus life cycle, is the most promising drug target for anti-flaviviral inhibitors, from which novel, anti-viral therapies will emerge. NS2bNS3 HTS Assay Protocol. Aprotinin, Sigma, A-4529. Brij-35 solution, 30%, Sigma, B4184-1L Dimethylsulfoxide, (DMSO) Sigma, 154938. Glycerol, Sigma, G5516-1L. Pyr-RTKR-AMC Substrate, BaChem  I-1650. Tris Base, Molecular Biology Grade, EMD Biosciences, 648310. Consumables  384-well black low-volume assay plate, Greiner 784076. 384-well low profile pyramid bottom reservoir, Innovative Microplate                 S30022 PK384 Robotic Tip series, 30uL Axygen, PK-384-R Preparation of Stock Solutions: Aprotinin, 1 mM: To make 1 mM Aprotinin dissolve 6.51 mg Aprotinin in 1 mL 20% glycerol.  Aliquot and store at -20#C. Aprotinin Inhibitor Solution: Prepare Fresh Daily 100 nM: Dilute .5 uL 1 mM Aprotinin and 150uL DMSO in 4.85 mL 20% glycerol. 3uM : Dilute 3uL 1mM Aprotinin and 30uL DMSO in 967uL 20% glycerol. 4uM : Dilute 4uL 1mM Aprotinin and 30uL DMSO in 967uL 20% glycerol. 10X Assay Buffer: 100 mM Tris, pH8.0, 0.05% Brij-35:  100 mL 1 M Tris, pH 8.0  1.67 mL 30% Brij-35 898.3 ml Milli-Q H2O                   Filter-sterilize 1X Assay Buffer: 1 mL 10X Assay Buffer 2 mL glycerol  7 mL Milli-Q H2O DMSO, 3%: Dilute DMSO to 3% in 20% glycerol. Pyr-RTKR-AMC, 1 mM: To make 1 mM Pyr-TRTK-AMC, dissolve 25 mg in 30 mL 20% glycerol. Aliquot and store at -20#C. Dilute 1mM stock to 180uM.  Prepare fresh daily. Glycerol, 20%:  Make a 20% solution of glycerol by mixing 200 mL glycerol with 800 mL Milli-Q H2O. Tris, 1 M, pH 8.0: Make a 1 M stock by dissolving 121 g Tris with 800 mL Milli-Q H2O. Adjust pH to 8.0 with HCl. Adjust final volume to 1 L. NS2b-NS3 Stock:  1 mg/mL stock in 1X Assay Buffer: Stored in -20#C freezer. NS2b-NS3 Enzyme solution; 2ug/mL NS2b/NS3, 10 mM Tris, pH 8.0, 0.005% Brij-35: Thaw enzyme on ice and dilute 1 mg/ml NS2b-NS3 to 2ug/mL in 3X Assay Buffer, 20% glycerol.   Prepare fresh daily. 3.0   mL 10X Assay Buffer 2.0   mL glycerol 20   uL 1 mg/ml NS2b-NS3 4.98 mL Milli-Q H2O Pyr-RTKR-AMC Substrate 180uM:  Dilute 180uL 1 mM Pyr-RTKR-AMC in 820uL 20% glycerol. Maximum Stimulation Control 5uL/ well 3% DMSO, 20% glycerol 5uL/well 2ug/ml NS2b-NS3 5uL/well 180uM Pyr-RTKR-AMC Minimum Stimulation Control 5uL/ well 3uM Aprotinin Inhibitor Solution 5uL/well 2ug/ml NS2b-NS3 5uL/well 180uM Pyr-RTKR-AMC 50% Stimulation Control 5uL/ well 100 nM Aprotinin Inhibitor Solution 5uL/well 2ug/ml NS2b-NS3 5uL/well 180uM Pyr-RTKR-AMC 1) Dilute compound plates in 20 % gluycerol. 10 to 100 uM final, 1% DMSO. 2) Transfer 5 uL of diluted compounds and plate controls in 20 % glycerol to wells of 384-well black low-volume 384-well assay plate, Greiner # 784076. 3) Transfer 5 uL/well 2 ug/ml NS2b-NS3 enzyme solution (3X assay buffer) to all wells. 4) Transfer 5 uL/well of 180 uM Pyr-RTKR-AMC substrate to all wells. 5) Centrifuge plate at 800xg for 30 secs-1 min. 6) Incubate assay plate at ambient temperature with shaking for 90 min. Do not stack plates! 7) Stop assay by transfer of 5 uL/well of 4 #M Aprotinin to assay plate. 8) Read fluorescence intensity at Ex 360 nm, Em 460 nm on the M5 plate reader.
bao:BAO_0000540 "577" ; # "is confirmatory assay of" -> "577"
bao:BAO_0000809 bao:BAO_0000030 ; # "has confirmatory assay" -> "confirmatory assay"
bao:BAO_0000205 bao:BAO_0000217 ; # "has assay format" -> "biochemical format"
bao:BAO_0000205 bao:BAO_0000224 ; # "has assay format" -> "protein format"
bao:BAO_0000205 bao:BAO_0000357 ; # "has assay format" -> "single protein format"
bao:BAO_0000409 bao:BAO_0000410 ; # "assay measurement type" -> "endpoint assay"
bao:BAO_0002850 bao:BAO_0000534 ; # "has assay readout content" -> "single readout"
bao:BAO_0002851 "single parameter" ; # "has assay readout content parametricity" -> "single parameter"
bao:BA0_0090012 bao:BAO_0000222 ; # "has participant" -> "generic hydrolase" || bao:BAO_0003102 bao:BAO_00020144 ; # "has role" -> "target"
bao:BAO_0002855 "hydrolase activity assay" ; # "is bioassay type of" -> "hydrolase activity assay"
bao:BAO_0000212 bao:BAO_0000124 ; # "has assay method" -> "enzyme activity measurement method"
bao:BAO_0000212 bao:BAO_0000139 ; # "has assay method" -> "direct enzyme activity measurement method"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> bao:BAO_0000484 ; # "has assay design method" -> "enzyme inhibition"
bao:BAO_0000207 bao:BAO_0000363 ; # "has detection method" -> "fluorescence intensity"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "To identify inhibitors of west nile virus NS2bNS3 proteinase" ; # "screening campaign name" -> "To identify inhibitors of west nile virus NS2bNS3 proteinase"
bao:BAO_0002853 "West Nile Virus NS2bNS3 Proteinase Inhibitor Dose Response Confirmation." ; # "has assay title" -> "West Nile Virus NS2bNS3 Proteinase Inhibitor Dose Response Confirmation."
bao:BAO_0002867 bao:BAO_0000515 ; # "has assay footprint" -> "384 well plate"
bao:BAO_0000109 "25 degree celsius" ; # "has temperature value" -> "25 degree celsius"
bao:BAO_0002833 "90 minute" ; # "has incubation time value" -> "90 minute"
bao:BA0_0090012 bao:BAO_0000852 ; # "has participant" -> "Pancreatic trypsin inhibitor"
bao:BAO_0000740 bao:BAO_0000080 ; # "has assay control" -> "positive control"
bao:BA0_0090012 bao:BAO_0000118 ; # "has participant" -> "DMSO"
bao:BAO_0000740 bao:BAO_0000079 ; # "has assay control" -> "negative control"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Alex Strongin" ; # "material entity assay provider" -> "Alex Strongin" || bao:BAO_0003102 bao:BAO_0000027 ; # "has role" -> "assay provider"
bao:BAO_0002020 bao:BAO_0000372 ; # "has assay phase characteristic" -> "homogeneous phase"
bao:BA0_0090012 bao:BAO_0000694 ; # "has participant" -> "Tris" || bao:BAO_0003102 <http://purl.obolibrary.org/obo/CHEBI_35225> ; # "has role" -> "buffer"
bao:BA0_0090012 bao:BAO_0000867 ; # "has participant" -> "Brij-35" || bao:BAO_0003102 <http://purl.obolibrary.org/obo/CHEBI_27780> ; # "has role" -> "detergent"
bao:BAO_0002000 bao:BAO_0000852 ; # "has measured entity" -> "Pancreatic trypsin inhibitor" || bao:BAO_0003102 <http://purl.obolibrary.org/obo/CHEBI_35222> ; # "has role" -> "inhibitor"
bao:BA0_0090012 bao:BAO_0001002 ; # "has participant" -> "Pyr-RTKR-AMC" || bao:BAO_0003102 bao:BAO_00020143 ; # "has role" -> "substrate"
bao:BA0_0090012 "Serine protease NS3" ; # "has participant" -> "Serine protease NS3"
bao:BAO_0002921 <http://purl.obolibrary.org/obo/NCBITaxon_11082> ; # "has organism" -> "West Nile virus"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "912267" ; # "gene ID" -> "912267"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "P06935" ; # "uniprot ID" -> "P06935"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "11082" ; # "NCBI taxonomy ID" -> "11082"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "912267" ; # "construct gene ID" -> "912267"
bao:BAO_0002662 bao:BAO_0002157 ; # "has quality" -> "native form"
bao:BAO_0002897 bao:BAO_0000360 ; # "has preparation method" -> "recombinant expression"
bao:BA0_0090012 bao:BAO_0000846 ; # "has participant" -> "7-amino-4-methylcoumarin"
bao:BAO_0002000 bao:BAO_0002001 ; # "has measured entity" -> "measured entity"
bao:BAO_0002857 bao:BAO_0000261 ; # "has signal direction" -> "signal decrease corresponding to inhibition"
bao:BA0_0090012 bao:BAO_0000176 ; # "has participant" -> "small molecule" || bao:BAO_0003102 bao:BAO_00020137 ; # "has role" -> "perturbagen"
bao:BAO_0000212 bao:BAO_0000574 ; # "has assay method" -> "single perturbagen"
bao:BAO_0002865 bao:BAO_0000706 ; # "uses detection instrument" -> "SpectraMax M5 Multi-Mode Microplate Reader"
bao:BAO_0000737 bao:BAO_0000969 ; # "has manufacturer" -> "Molecular Devices" || bao:BAO_0003102 bao:BAO_0002628 ; # "has role" -> "instrumentation manufacturer"
bao:BAO_0002917 "360 nanometer" ; # "has excitation wavelength value" -> "360 nanometer"
bao:BAO_0002918 "460 nanometer" ; # "has emission wavelength value" -> "460 nanometer"
bao:BAO_0000337 bao:BAO_0000201 ; # "has percent response" -> "percent inhibition"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "5" ; # "PubChem TID" -> "5"
bao:BAO_0000182 <http://purl.org/obo/owl/UO#UO_0000187> ; # "has response unit" -> "percent"
bao:BAO_0002666 "50" ; # "has concentration value" -> "50"
bao:BAO_0000183 <http://purl.org/obo/owl/UO#UO_0000064> ; # "has concentration unit" -> "micromolar"
bao:BAO_0002787 "1" ; # "has concentration-point number" -> "1"
bao:BAO_0000196 bao:BAO_0000091 ; # "has mode of action" -> "inhibition"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "kunie-2" ; # "Annotated by" -> "kunie-2"
bao:BAO_0000208 bao:BAO_0000190 ; # "has endpoint" -> "IC50"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "2" ; # "PubChem TID" -> "2"
bao:BAO_0002787 "10" ; # "has concentration-point number" -> "10"
